Our Purpose
Life Unlimited
Smith & Nephew is a leading portfolio medical technology company, focussed on the repair, regeneration and replacement of soft & hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living.
Advanced Wound Management
Smith+Nephew’s Advanced Wound Management portfolio provides comprehensive solutions to meet broad and complex clinical needs and to help healthcare professionals reduce the human and economic consequences of wounds. These include products for the treatment of acute and chronic wounds such as leg, diabetic and pressure ulcers, burns, and post-operative wounds.
We are a global medical device company that delivers improved patient outcomes through our unique NovoSorb biodegradable polymer technology.
Our product, NovoSorb BTM is a bioabsorbable synthetic matrix that provides a scaffold for robust vascularised dermal reconstruction.
NovoSorb BTM is indicated for full or deep partial thickness burns and wounds, surgical and reconstructive wounds and traumatic wounds.
We are Mölnlycke® – a world-leading medical product and solutions company with people at our heart. We are here to advance performance in healthcare across the world. Our organisation is made up of four decentralised Business Areas, and while each Area has end-to-end responsibility for performance and operational excellence, we are united by the principles that guide us in everything we do: customer-centricity, digitalisation, sustainability, innovation and culture.
Our wound care and pressure injury prevention products are aimed at both the acute and the community healthcare sectors. The goal is simple – to further the science and practice of wound care to reduce pain and suffering for patients. We insist on excellence at every step, from the construction of a dressing to the way we interact with our customers.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Ophthalmology and Aesthetic markets. As a world-renowned expert in developing and commercialising innovative energy based technologies, including Laser, Intense Pulsed Light (IPL) and Radiofrequency (RF), Lumenis has redefined medical treatments and set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionised existing treatment methods in each and every one of the sectors that we operate within. Our drive for innovation stems from an uncompromising commitment to improve the health and well-being of our patients: addressing new and growing needs of aging populations: and in offering medical professionals cutting edge solutions that fit seamlessly into the health-economics environment of the 21st century.
With many years of international dermatological expertise, Swiss company Stratpharma has developed breakthrough treatments for faster wound healing, abnormal scar prevention and treatment that are now available in over 50 countries. These medical grade silicone products are clinically proven to be effective and easy to use alone or in combination with more invasive therapies.
Stratpharma’s range includes: Stratamed – the first film-forming silicone wound dressing approved for use on open wounds and compromised skin; Strataderm – for the treatment of old and new scars; Stratamark – for the prevention and treatment of stretch marks; Stratacel -the film-forming silicone wound dressing for use post resurfacing procedure.
Website:
https://stratpharma.com/
